[HTML][HTML] Ligands of epidermal growth factor receptor and the insulin-like growth factor family as serum biomarkers for response to epidermal growth factor receptor …
MA Vollebergh, I Kappers, HM Klomp… - Journal of Thoracic …, 2010 - Elsevier
Introduction The selection of patients with non-small cell lung cancer (NSCLC) for epidermal
growth factor receptor (EGFR) inhibitor (EGFR-tyrosine kinase inhibitors [TKIs]) therapy is …
growth factor receptor (EGFR) inhibitor (EGFR-tyrosine kinase inhibitors [TKIs]) therapy is …
Ligands of epidermal growth factor receptor and the insulin-like growth factor family as serum biomarkers for response to epidermal growth factor receptor inhibitors in …
MA Vollebergh, I Kappers… - Journal of thoracic …, 2010 - pubmed.ncbi.nlm.nih.gov
Introduction The selection of patients with non-small cell lung cancer (NSCLC) for epidermal
growth factor receptor (EGFR) inhibitor (EGFR-tyrosine kinase inhibitors [TKIs]) therapy is …
growth factor receptor (EGFR) inhibitor (EGFR-tyrosine kinase inhibitors [TKIs]) therapy is …
[引用][C] Ligands of epidermal growth factor receptor and the insulin-like growth factor family as serum biomarkers for response to epidermal growth factor receptor …
V MA - J Thorac Oncol, 2010 - cir.nii.ac.jp
Ligands of epidermal growth factor receptor and the insulin-like growth factor family as serum
biomarkers for response to epidermal growth factor receptor inhibitors in patients with advanced …
biomarkers for response to epidermal growth factor receptor inhibitors in patients with advanced …
Ligands of Epidermal Growth Factor Receptor and the Insulin-Like Growth Factor Family as Serum Biomarkers for Response to Epidermal Growth Factor Receptor …
MA Vollebergh, I Kappers, HM Klomp… - Journal of Thoracic …, 2010 - jto.org
Introduction The selection of patients with non-small cell lung cancer (NSCLC) for epidermal
growth factor receptor (EGFR) inhibitor (EGFR-tyrosine kinase inhibitors [TKIs]) therapy is …
growth factor receptor (EGFR) inhibitor (EGFR-tyrosine kinase inhibitors [TKIs]) therapy is …
Ligands of epidermal growth factor receptor and the insulin-like growth factor family as serum biomarkers for response to epidermal growth factor receptor inhibitors in …
MA Vollebergh, I Kappers, HM Klomp… - Journal of Thoracic …, 2010 - europepmc.org
Methods We assessed serum levels of marker candidates using enzyme-linked
immunosorbent (TGFa and ARG) and chemiluminescent (IGF1 and IGF-binding protein-3) …
immunosorbent (TGFa and ARG) and chemiluminescent (IGF1 and IGF-binding protein-3) …
[PDF][PDF] Ligands of Epidermal Growth Factor Receptor and the Insulin-Like Growth Factor Family as Serum Biomarkers for Response to Epidermal Growth Factor …
MA Vollebergh, I Kappers, HM Klomp… - Journal of Thoracic …, 2010 - core.ac.uk
Ligands of Epidermal Growth Factor Receptor and the Insulin-Like Growth Factor Family as
Serum Biomarkers for Response to Epider Page 1 ORIGINAL ARTICLE Ligands of Epidermal …
Serum Biomarkers for Response to Epider Page 1 ORIGINAL ARTICLE Ligands of Epidermal …